Skip to content
10-Q

Quarterly Report

SANARA MEDTECH INC. SMTI

0001493152-25-021894

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 8.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.91M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.47M sh
Capex Q3 2025 · Sep 30, 2025 $4.54M
Capex Q3 2025 · Sep 30, 2024 $133.68K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $2.84M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$955.83K
Long Term Debt Q3 2025 · Sep 30, 2025 $45.09M
Long Term Debt Q3 2025 · Dec 31, 2024 $30.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $14.94M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $15.88M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.15M
Stockholders Equity Q3 2025 · Dec 31, 2024 $39.4M
Current Liabilities Q3 2025 · Sep 30, 2025 $17.36M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.29M
Total Liabilities Q3 2025 · Sep 30, 2025 $64.95M
Total Liabilities Q3 2025 · Dec 31, 2024 $49.18M
Current Assets Q3 2025 · Sep 30, 2025 $31.23M
Current Assets Q3 2025 · Dec 31, 2024 $33.31M
Total Assets Q3 2025 · Sep 30, 2025 $71.09M
Total Assets Q3 2025 · Dec 31, 2024 $88.09M
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.40
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.34
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.96
Eps Basic Q3 2025 · Sep 30, 2025 −$3.52
Eps Basic Q3 2025 · Sep 30, 2025 −$4.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.34
Eps Basic Q3 2025 · Sep 30, 2024 −$0.96
Sga Expense Q3 2025 · Sep 30, 2025 $19.88M
Sga Expense Q3 2025 · Sep 30, 2025 $58.64M
Sga Expense restated Q3 2025 · Sep 30, 2024 $17.42M
Sga Expense restated Q3 2025 · Sep 30, 2024 $51.45M
Rd Expense Q3 2025 · Sep 30, 2025 $1.03M
Rd Expense Q3 2025 · Sep 30, 2025 $3.04M
Rd Expense restated Q3 2025 · Sep 30, 2024 $783.84K
Rd Expense restated Q3 2025 · Sep 30, 2024 $1.95M
Net Income Q3 2025 · Sep 30, 2025 −$30.41M
Net Income Q3 2025 · Sep 30, 2025 −$35.95M
Net Income Q3 2025 · Sep 30, 2024 −$2.86M
Net Income Q3 2025 · Sep 30, 2024 −$8.13M
Operating Income Q3 2025 · Sep 30, 2025 $2.94M
Operating Income Q3 2025 · Sep 30, 2025 $6.25M
Operating Income restated Q3 2025 · Sep 30, 2024 $778.54K
Operating Income restated Q3 2025 · Sep 30, 2024 −$1M
Gross Profit Q3 2025 · Sep 30, 2025 $24.46M
Gross Profit Q3 2025 · Sep 30, 2025 $69.93M
Gross Profit Q3 2025 · Sep 30, 2024 $19.68M
Gross Profit Q3 2025 · Sep 30, 2024 $54.48M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.87M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $5.65M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.99M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $5.89M
Revenue Q3 2025 · Sep 30, 2025 $26.33M
Revenue Q3 2025 · Sep 30, 2025 $75.57M
Revenue Q3 2025 · Sep 30, 2024 $21.67M
Revenue Q3 2025 · Sep 30, 2024 $60.37M